Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MESEMS: Autologous MSCs for Multiple Sclerosis
NCT01854957Phase 2Unknown
- Start
- Jul 2012
- Primary completion
- Jul 2014
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in multiple sclerosis (MS). Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01854957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01854957.